Sentence examples for partial responsiveness from inspiring English sources

The therapeutic effect of chemotherapy was assessed in terms of partial responsiveness, stable disease, and progressive disease in accordance with the Response Evaluation Criteria in Solid Tumors.

In order to understand the partial responsiveness to IFNß in Relapsing Remitting MS (RRMS) we studied the pharmacological effects of IFNß therapy.

These disorders are important to recognize because of their partial responsiveness to CoQ10 supplementation.

Diazoxide was used as an adjunct in seven patients as there was clinical evidence of partial responsiveness to diazoxide with improvement in blood glucose concentrations.

Treatment responsiveness was defined according to the following definitions: 'good' indicated a satisfactory responsiveness with a complete disappearance of signs, 'partial' indicated partial responsiveness with an incomplete disappearance of signs, and 'poor' indicated unresponsiveness.

However, patients whose responsiveness to chemotherapy were progressive disease tended to show a relatively high frequency of CD4+PD-1+ cells in the peripheral blood compared to patients with a diagnosed therapeutic effect of stable disease or partial responsiveness with chemotherapy, whereas this was not observed for CD4+CD25+CD127low/− T cells (Fig. 5g, h).

Limited changes in the residues of the peptide or in the MHC binding site alter the T cell response: to non-responsiveness, partial response leading to "anergy" and to differences in proliferation and cytokine response [ 38, 39].

In contrast, a triple mutant of subfamily 2 receptors is primarily distinguished by an increase in its ethylene sensitivity such that it exhibits a partial triple response phenotype due to its responsiveness to endogenous ethylene levels in the seedling [ 22].

Of the cases with 'good' or 'partial' responsiveness, the median number of days to a response to initial treatment was 42.5 days in the Ss group (range: 20-91) and 285 days in the Ls group (range: 196-1026).

Thirty-seven cervical dystonia patients with NABTs and partial secondary non-responsiveness to their previous botulinum neurotoxin type A treatment.

To test our hypothesis, we prospectively analysed NABTs in an immunologically critical subgroup of patients with NABTs and partial secondary non-responsiveness who were switched from long-term treatment with other botulinumtoxin A preparations to incobotulinumtoxinA treatment.